Skip to main content

Research Repository

Advanced Search

TICH-2 Trial – Tranexamic Acid for Intracerebral Haemorrhage 2

Sprigg, Nikola; Bath, Philip M.W.; Appleton, J.; Law, Z.; Flaherty, Katie; Scutt, Polly; Hyman-Taylor, Pauline; Adrian, M.; Stringer, M.; Longmate, J.; Gray, R.; Gregory, H.; Lysons, C.; Ali, A.

Authors

NIKOLA SPRIGG nikola.sprigg@nottingham.ac.uk
Professor of Stroke Medicine

PHILIP BATH philip.bath@nottingham.ac.uk
Stroke Association Professor of Stroke Medicine

J. Appleton

Z. Law

Katie Flaherty

Polly Scutt

Pauline Hyman-Taylor

M. Adrian

M. Stringer

J. Longmate

R. Gray

H. Gregory

C. Lysons

A. Ali



Abstract

Rationale: To assess in a pragmatic phase III prospective double blind randomised placebo-controlled trial whether tranexamic acid is safe and reduces death or dependency after spontaneous intracerebral haemorrhage (SICH). The results will determine whether tranexamic acid should be used to treat ICH.
Design: Patients will be randomised (1:1) to receive either tranexamic acid or placebo (0.9 % saline) within 8 hours of acute SICH. Randomisation will be computerised and minimised on key prognostics age; sex; time since onset; systolic blood pressure; stroke severity (NIHSS); presence of intraventricular haemorrhage and known history of antiplatelet treatment. Patients, investigators and outcome assessors will be blind to treatment allocation. The primary outcome is death or dependency (modified Rankin Scale) and telephone follow-up is at day 90.
Trial status: The start-up phase of the trial commenced on 1st March 2013, the main phase commenced 1st April 2014. The recruitment target was 300 participants in the startup phase and 2,000 in the main phase. As of 30th May 2017, 2191 patients have been recruited from 123 centres (UK, Georgia, Italy, Malaysia, Switzerland, Republic of Ireland, Turkey, Sweden, Denmark, Hungary, Spain and Poland). The objective was to have 80 UK centres and 40 international centres.

Citation

Sprigg, N., Bath, P. M., Appleton, J., Law, Z., Flaherty, K., Scutt, P., …Ali, A. (2017). TICH-2 Trial – Tranexamic Acid for Intracerebral Haemorrhage 2.

Conference Name 12th UK Stroke Forum Conference (UKSF 2017)
End Date Nov 30, 2017
Acceptance Date Aug 1, 2017
Publication Date Nov 30, 2017
Deposit Date Apr 6, 2018
Publicly Available Date Mar 29, 2024
Peer Reviewed Peer Reviewed
Public URL https://nottingham-repository.worktribe.com/output/897440
Related Public URLs https://www.stroke.org.uk/sites/default/files/uksf_17_lr.pdf

Files





You might also like



Downloadable Citations